Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.
Yang Y, Guo Y, Luo H, Wang M, Chen F, Cui H, Chen P, Yin Z, Li L, Dai Y, Zeng J, Zhao J.
Yang Y, et al. Among authors: zeng j.
Front Pharmacol. 2023 Apr 4;14:1164827. doi: 10.3389/fphar.2023.1164827. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37081969
Free PMC article.